1. Search Result

Search Result

Results for "1973403-00-7" in MCE Product Catalog:

Cat. No. Product Name Target Research Area
  • HY-130492
    ARCC-4

    PROTAC Androgen Receptor Cancer
    ARCC-4 is a low-nanomolar androgen receptor (AR) degrader based on PROTAC, with a DC50 of 5 nM. ARCC-4 is an enzalutamide-based von Hippel-Lindau (VHL)-recruiting AR PROTAC and outperforms enzalutamide. ARCC-4 effectively degrades clinically relevant AR mutants associated with antiandrogen therapy.